1. Home
  2. LRMR vs CVGW Comparison

LRMR vs CVGW Comparison

Compare LRMR & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • CVGW
  • Stock Information
  • Founded
  • LRMR N/A
  • CVGW 1924
  • Country
  • LRMR United States
  • CVGW United States
  • Employees
  • LRMR N/A
  • CVGW N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • CVGW Specialty Foods
  • Sector
  • LRMR Health Care
  • CVGW Consumer Discretionary
  • Exchange
  • LRMR Nasdaq
  • CVGW Nasdaq
  • Market Cap
  • LRMR 332.1M
  • CVGW 396.5M
  • IPO Year
  • LRMR N/A
  • CVGW N/A
  • Fundamental
  • Price
  • LRMR $3.45
  • CVGW $21.87
  • Analyst Decision
  • LRMR Strong Buy
  • CVGW Strong Buy
  • Analyst Count
  • LRMR 7
  • CVGW 1
  • Target Price
  • LRMR $16.71
  • CVGW $40.00
  • AVG Volume (30 Days)
  • LRMR 1.8M
  • CVGW 157.4K
  • Earning Date
  • LRMR 11-05-2025
  • CVGW 09-09-2025
  • Dividend Yield
  • LRMR N/A
  • CVGW 3.66%
  • EPS Growth
  • LRMR N/A
  • CVGW N/A
  • EPS
  • LRMR N/A
  • CVGW 0.88
  • Revenue
  • LRMR N/A
  • CVGW $693,712,000.00
  • Revenue This Year
  • LRMR N/A
  • CVGW $4.46
  • Revenue Next Year
  • LRMR N/A
  • CVGW $6.86
  • P/E Ratio
  • LRMR N/A
  • CVGW $24.81
  • Revenue Growth
  • LRMR N/A
  • CVGW 9.46
  • 52 Week Low
  • LRMR $1.61
  • CVGW $21.46
  • 52 Week High
  • LRMR $9.50
  • CVGW $30.02
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 39.35
  • CVGW 21.01
  • Support Level
  • LRMR $3.16
  • CVGW $22.07
  • Resistance Level
  • LRMR $4.50
  • CVGW $22.69
  • Average True Range (ATR)
  • LRMR 0.30
  • CVGW 0.51
  • MACD
  • LRMR -0.10
  • CVGW -0.04
  • Stochastic Oscillator
  • LRMR 24.09
  • CVGW 0.00

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About CVGW Calavo Growers Inc.

Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The group markets and distribute avocados, prepared avocado products, and other perishable foods to retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers across the world. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.

Share on Social Networks: